# Tolterodine Tartrate (Tolterodine Tartrate Extended Release)

Source: https://ourhealthnetwork.com/drugs/tolterodine-tartrate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Tolterodine Tartrate?

Tolterodine Tartrate (brand name: Tolterodine Tartrate Extended Release) is an antimuscarinic. It is prescribed to treat urinary bladder diseases, urinary incontinence. Across the United States, 18,000 doctors prescribe Tolterodine to approximately 32,000 Medicare patients.

## Brand names

Tolterodine Tartrate Extended Release

## Indications

Tolterodine Tartrate is prescribed for the treatment of urinary bladder diseases and urinary incontinence.

## Conditions treated

- [Urinary Bladder Diseases](https://ourhealthnetwork.com/conditions/urinary-bladder-diseases)
- [Urinary Incontinence](https://ourhealthnetwork.com/conditions/urinary-incontinence)

## Mechanism of action

Tolterodine acts as a competitive antagonist of acetylcholine at postganglionic muscarinic receptors. Both urinary bladder contraction and salivation are mediated via cholinergic muscarinic receptors.

## Drug classification

- Established Pharmacologic Class: antimuscarinics
- Route of administration: ORAL

## Common side effects

abdominal pain, constipation, dry mouth, headache

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)